Wearable device can reduce fat, treat type 2 diabetes
The device developed by Kumamoto University affects visceral fat loss and improves blood glucose (sugar) by helping overweight or elderly people exercise, which is effective for the treatment of diabetes.
Type 2 diabetes is a disease of systemic organ failure due to chronic hyperglycemia and inflammation from the accumulation of excess visceral fat.
Metabolic disorders such as hyperglycemia attenuate stress resistance in the human body and exacerbate insulin resistance.
The heat shock response (HSR) is activated as a response to stress in the human body, but its function decreased in those with type 2 diabetes.
A research team from the university has found that by restoring the function of HSP72 — the main protein of HSR — improved glucose-related abnormalities.
The researchers developed a belt-type medical device that uses a special type of rubber.
“This device is very easy to use since it simply attaches to the abdomen and it has a low-impact on the patient. One can expect the effects to be similar to exercise therapy,” Tatsuya Kondo, who led the research, said in a statement.
The team then performed a clinical trial of MES + HS on 40 obese men suffering from type 2 diabetes.
Results showed a decrease fasting glucose levels, a loss of visceral fat, improve insulin resistance and a significant improvement in glycated hemoglobin (HbA1c) values.
The research appeared in journal Scientific Reports.
